Introducing the new Spruson & Ferguson brand
Today, Spruson & Ferguson is proud to unveil our new brand. Our new brand builds on our position as a market leader in intellectual property services, and defines what will...
Today, Spruson & Ferguson is proud to unveil our new brand. Our new brand builds on our position as a...
Read More
ToolGen unsuccessful in landmark CRISPR patent appeal
The Federal Court of Australia has delivered judgement in Australia’s landmark CRISPR patent dispute, finding that none of the claims in ToolGen Inc.’s patent application for platform CRISPR technologies...
The Federal Court of Australia has delivered judgement in Australia’s landmark CRISPR patent dispute, finding that none of the...
Read More
Understanding Australia’s Experimental Use Exemption to Patent Infringement
Background to Patent Infringement An Australian patent provides to its owner the exclusive rights to exploit a patented invention during the patent term within Australia. The owner has a legal...
Background to Patent Infringement An Australian patent provides to its owner the exclusive rights to exploit a patented invention during...
Read More
Australian patent office refuses to extend the time for making biological deposits
The Budapest Treaty provides a mechanism whereby patent applicants can sufficiently “describe” a biological invention by making a deposit of biological material with a recognised international depositary authority. To...
The Budapest Treaty provides a mechanism whereby patent applicants can sufficiently “describe” a biological invention by making a deposit...
Read More
Keywords go viral: Covid-19 sweeps around the patent world
Covid-19 is not just a once-in-a-lifetime pandemic sweeping across the globe causing hardships and sorrows; it’s also a new word, and the opportunity to look at it through a...
Covid-19 is not just a once-in-a-lifetime pandemic sweeping across the globe causing hardships and sorrows; it’s also a new...
Read More
Validity and infringement of diagnostic method claims
Ariosa Diagnostics, Inc v Sequenom, Inc FCAFC 101 The Full Court of the Federal Court of Australia has confirmed that Sequenom’s diagnostic method of detecting fetal DNA in maternal...
Ariosa Diagnostics, Inc v Sequenom, Inc FCAFC 101 The Full Court of the Federal Court of Australia has confirmed...
Read More
Australian Patent Office considers the plausibility of Swiss-style claims
Gliknik, Inc. v CSL Behring Lengnau AG  APO 46 (“Gliknik”) concerned a patent application for engineered proteins intended for use as replacements for intravenous immunoglobulin.  The application included claims...
Gliknik, Inc. v CSL Behring Lengnau AG  APO 46 (“Gliknik”) concerned a patent application for engineered proteins intended for...
Read More
Pharmaceutical patent term extensions: broader is not always better
Ono Pharmaceutical Co., Ltd. et al  APO 43 (16 September 2020) Background Australia’s Patents Act provides a patent term extension (PTE) to account for the delays that can occur when obtaining...
Ono Pharmaceutical Co., Ltd. et al  APO 43 (16 September 2020) Background Australia’s Patents Act provides a patent term extension (PTE)...
Read More
How to use post-filing experimental data to help establish sufficiency and support
The Intellectual Property Laws Amendment (Raising the Bar) Act 2012 was introduced in Australia with the intention of aligning Australia’s written description requirements with those in the UK and Europe. Under...
The Intellectual Property Laws Amendment (Raising the Bar) Act 2012 was introduced in Australia with the intention of aligning Australia’s written...
Read More
Patenting proteins: an Australian perspective
Biological molecules, including polypeptides and, in some cases, nucleic acids, can be patented under Australian law.  The level of disclosure that is required to support and enable a claim...
Biological molecules, including polypeptides and, in some cases, nucleic acids, can be patented under Australian law.  The level of...
Read More

Contact our Expert Team

Contact Us
Contact Us